Reneuron Group

ReNeuron is a leading, UK-based stem cell company. Our primary objective is the development of stem cell therapies targeting areas of significant unmet or poorly met medical need
Type
Public
HQ
Surrey Research Park, GB
Founded
1997
Size (employees)
44 (est)+34%
Reneuron Group was founded in 1997 and is headquartered in Surrey Research Park, GB

Key People at Reneuron Group

John Sinden

John Sinden

CSO

Reneuron Group Office Locations

Reneuron Group has an office in Surrey Research Park
Surrey Research Park, GB (HQ)
10 Nugent Rd

Reneuron Group Data and Metrics

Reneuron Group Financial Metrics

Reneuron Group's revenue was reported to be £29 k in FY, 2016 which is a 3% decrease from the previous period.
GBP

Revenue (FY, 2016)

29 k

Revenue growth (FY, 2015 - FY, 2016), %

(3%)

Net income (FY, 2016)

(11.4 m)

Market capitalization (20-Jul-2017)

57 m

Closing share price (20-Jul-2017)

0

Cash (31-Mar-2016)

60.7 m
Reneuron Group's current market capitalization is £57 m.
GBPFY, 2014FY, 2015FY, 2016

Revenue

22 k30 k29 k

Revenue growth, %

36%(3%)

Pre tax profit

(7.8 k)(10.3 m)(12.8 m)

Net Income

(7.1 k)(8.9 m)(11.4 m)
GBPFY, 2014FY, 2015FY, 2016

Cash

14.9 k12.4 m60.7 m

Accounts Receivable

386

Current Assets

22.3 k14.1 m64.9 m

PP&E

500442 k5.4 m

Goodwill

1.3 k1.6 m1.6 m

Total Assets

24.1 k16.1 m71.9 m

Accounts Payable

1.2 k1.1 m1.5 m

Current Liabilities

2 k2.3 m4.2 m

Total Liabilities

2.4 k3 m4.2 m

Retained Earnings

(7.1 k)(8.9 m)(11.4 m)

Total Equity

21.7 k13.1 m67.7 m

Financial Leverage

1.1 x1.2 x1.1 x
GBPFY, 2014FY, 2015FY, 2016

Cash From Operating Activities

(6 k)(8.2 m)(11.9 m)

Cash From Financing Activities

17.4 k6 m16.9 m

Income Taxes Paid

7541.4 m1.5 m
GBPY, 2016

Revenue/Employee

878.8

Financial Leverage

1.1 x

Reneuron Group Market Value History

Reneuron Group Company Life and Culture

You may also be interested in